MedTrace Logo

Co-designing Enhanced Models of Care for First Nations Children at Risk for Childhood-onset Type 2 Diabetes

NCT07692321 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-08-03

No results posted yet for this study

Summary

The overall objective: to co-design and implement targeted and timely community led strategies to improve the health of the Next Generation and end the intergenerational impact of T2D in this population.

Conditions

Interventions

BEHAVIORAL

Breastfeeding and perinatal education and support

Co-develop and implement a community-based perinatal education and support program using navigators to support breast feeding, maternal nutrition and activity, and early infancy/childhood nutrition and activity.

DEVICE

Purchasing HbA1c machines for communities

This will allow study participants to conduct earlier and more frequent screening for early dysglycemia, prediabetes and T2D.

DEVICE

Continuous Glucose Monitoring

We will investigate the use of continuous glucose monitoring (CGM) to detect early dysglycemia in the Next Gen cohort.

BEHAVIORAL

Land-based Wellness Programming

Co-develop and implement community led land-based programming for parent(s) and preschool children aged 4-5 years to encourage traditional nutrition and activities to maintain wellness.

Sponsors & Collaborators

  • Children's Hospital Research Institute of Manitoba

    collaborator OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • University of Manitoba

    lead OTHER

Principal Investigators

  • Brandy A Wicklow, MD, MSc · University of Manitoba, Children's Hospital Research Institute of Manitoba

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2030-06-30
Completion
2031-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07692321 on ClinicalTrials.gov